CHRNA5 rs16964201: What Your Genotype Means
The rs16964201 variant is a common genetic change located within the CHRNA5 gene. It is widely recognized in scientific literature for its association with nicotine dependence and variations in smoking behavior.
What each genotype means
Typical nicotine receptor function
This genotype represents the most common form of the CHRNA5 gene variant. Research suggests individuals with this profile do not carry the specific genetic association linked to increased nicotine dependence or higher daily cigarette consumption often observed with the alternative allele. Please discuss any concerns regarding smoking behavior or cessation strategies with your healthcare provider.
This is the most common genotype in most global populations.
Increased nicotine dependence risk
Carrying one copy of the T allele is associated with a statistically higher likelihood of nicotine dependence and increased daily cigarette consumption compared to those without it. This variant may influence how your brain responds to nicotine, potentially making it more challenging to quit smoking. Please consult with a clinician or pharmacist to discuss personalized smoking cessation support and evidence-based treatment options.
This genotype is common, appearing in a significant portion of individuals across many ancestral groups.
Higher nicotine dependence risk
Individuals with two copies of the T allele show a stronger statistical association with nicotine dependence and higher daily cigarette consumption than those with the CC or CT genotypes. This variant is thought to alter the function of nicotinic receptors in the brain, which may impact your experience with nicotine and the difficulty of cessation. You should discuss your smoking habits and potential cessation aids with a healthcare professional to determine the best approach for your needs.
This genotype is less common than the heterozygous CT state but is present in a notable percentage of the population.
Understanding the Variant
The rs16964201 variant is a single-nucleotide polymorphism (SNP) located on chromosome 15 within the CHRNA5 gene. This gene is part of a cluster of nicotinic acetylcholine receptor genes that play a critical role in how the brain responds to nicotine. In genetic research, rs16964201 is frequently studied because it involves a change in the DNA sequence that can alter the structure of the resulting protein. Because this variant is common, it has been the subject of numerous large-scale genome-wide association studies (GWAS) aimed at understanding the biological underpinnings of tobacco use. By examining this specific location in the genome, researchers have been able to identify consistent patterns linking this genetic marker to how individuals interact with nicotine, providing insights into why some people may find it more challenging to quit smoking than others.
The Role of the CHRNA5 Gene
The CHRNA5 gene provides instructions for making a subunit of the nicotinic acetylcholine receptor, which is found in various parts of the brain. These receptors are activated by nicotine, a primary component of tobacco products. When nicotine binds to these receptors, it triggers the release of neurotransmitters like dopamine, which are associated with feelings of reward and pleasure. The specific protein produced by CHRNA5 helps regulate the sensitivity and activity of these receptors. Variations in this gene, such as rs16964201, can lead to changes in the receptor's function, potentially affecting how much nicotine an individual consumes or how dependent they become on the substance. Understanding this biological mechanism is a major focus of addiction research, as it highlights how inherited genetic differences can influence the neurobiology of reward pathways and substance use behaviors.
Research and Evidence
The evidence linking rs16964201 to smoking behavior is considered moderate to strong, particularly in populations of European ancestry. Multiple large-scale studies have consistently identified this variant as a significant factor in nicotine dependence, often measured by the number of cigarettes smoked per day or scores on the Fagerström Test for Nicotine Dependence. While the association is robust in many studies, researchers note that the effect size is relatively small, meaning that this single variant is only one of many factors—including environmental, social, and other genetic influences—that contribute to smoking habits. Furthermore, while the signal is strong in European populations, its impact and frequency can vary across different ancestral groups. Ongoing research continues to explore how this variant interacts with other genes in the 15q25.1 cluster to influence long-term smoking cessation outcomes and related health traits.
Population Frequency
The rs16964201 variant is considered a common polymorphism, meaning it is found at relatively high frequencies across many human populations. While the exact distribution can vary depending on geographic and ancestral background, it is frequently observed in large-scale genomic databases. This high frequency allows researchers to conduct powerful statistical analyses to confirm its association with smoking-related traits. Because it is so common, many individuals carry at least one copy of the variant, making it a standard marker in studies investigating the genetic architecture of substance use. Despite its prevalence, the presence of the variant does not guarantee any specific outcome, as it is merely one piece of a complex genetic puzzle that influences human behavior and health.
What This Information Means for You
It is important to understand that genetic variants like rs16964201 are associated with statistical trends in large populations, not individual medical outcomes. Having a specific genotype does not mean you are destined to become nicotine dependent, nor does it mean you are immune to it. Smoking behavior is influenced by a complex interplay of genetics, environment, and personal choice. If you are concerned about nicotine use or are looking for support with smoking cessation, the most effective approach is to consult with a healthcare professional. They can provide personalized guidance, evidence-based strategies, and resources tailored to your specific needs. Never use genetic information to make medical decisions or change your health habits without first discussing the implications with a qualified clinician or pharmacist who can interpret these results in the context of your overall health.
How common is this variant?
The rs16964201 variant is common across diverse global populations, with its specific allele frequencies varying significantly by ancestral background.
Frequently asked questions
Does having the rs16964201 variant mean I will become addicted to nicotine?
No. Genetic variants only indicate a statistical predisposition in large groups. Many factors, including your environment and personal choices, play a much larger role in whether or not you develop nicotine dependence.
Can I use this genetic information to help me quit smoking?
Genetic information is not a substitute for professional medical advice. If you are trying to quit smoking, please speak with your doctor or pharmacist about evidence-based cessation programs and treatments that are proven to be effective.
Is this variant only found in people of European descent?
No, this variant is found in many populations worldwide. However, the strength of its association with smoking behavior has been most extensively studied and replicated in populations of European ancestry.
Where can I find more information about my specific genetic results?
If you have received genetic testing results, you should discuss them with a genetic counselor or your primary care physician. They can help you understand what these results mean for your health and how to interpret them accurately.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs16964201?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CHRNA5
This variant is a lead SNP associated with nicotine dependence in individuals of European ancestry.
This variant serves as a lead SNP in cross-ancestry analyses of nicotine dependence.
This variant is strongly associated with an increased risk of nicotine dependence and higher cigarette consumption per day.
Significantly increases the risk of nicotine dependence and lung cancer.
This SNP is a well-known risk factor for nicotine dependence and lung cancer.